RCAG
PTLA

Rehmann Capital Advisory Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Rehmann Capital Advisory Group’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		$4.53K Buy
169
+63
+59% +$1.69K ﹤0.01% 1236
2019
Q2 		$2.88K Hold
106
– – ﹤0.01% 1702
2019
Q1 		$3.68K Buy
+106
New +$3.68K ﹤0.01% 1608